GEN News Highlights

Caliper Life Sciences and Seegene are teaming up to apply Seegene’s SeePlex™ multiplex diagnostic assays to Caliper’s LabChip® Dx platform. The firms say they will co-market the LabChip Dx platform and complete line of Seegene’s multiplex diagnostics straight away, and work together to expand the number of diagnostic tests available, which will be offered as co-branded products. Outside the U.S. the SeePlex assays will be marketed and distributed for use with the LabChip Dx through a preferred partnership agreement with Seegene’s distributors.

Seegene’s Dual Priming Oligonucleotide (DPO) approach to PCR-based assays uses a technique for DNA priming that is structurally and functionally different from traditional methods, the firm claims. “We believe that Seegene’s DPO technology uniquely enables sensitive and specific, highly multiplexed assays directly from clinical samples, significantly improving the economics of today for centralized and hospital-based diagnostic testing,” adds Kevin Hrusovsky, Caliper’s president and CEO. “This agreement to partner with Seegene’s innovative multiplex diagnostic content on the LabChip Dx platform should dramatically improve the economics of diagnostic testing and pave the way for the development of critical diagnostics to accelerate the worldwide implementation of personalized medicine.”

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

42.9%

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

14.3%

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.